Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the company will participate in the J.P. Morgan Healthcare Conference on January 15, 2020 in San Francisco, CA. Amir...

Envista Holdings Corporation (NYSE: NVST) ("Envista") will report financial results for its fourth quarter 2019 on Thursday, January 30, 2020, after market close. Envista will discuss these...

Envista is proud to announce the Nobel Biocare Global Symposium 2020, to be held in Las Vegas, April 16 – 18. Empowered by a combination of expert knowledge and innovative solutions that are...

Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that it is now a fully independent company. The closing of Danaher Corporation's ("Danaher") exchange offer completes the...

Envista Holdings Corporation (NYSE: NVST) announced it intends to file a Form S-4/S-1 Registration Statement today with the Securities and Exchange Commission (SEC) in connection with Danaher's...

Envista Holdings Corporation (NYSE: NVST) today announced results for the third quarter 2019. Envista operated as part of Danaher Corporation until its separation in September 2019. The historical...

Envista Holdings Corporation (NYSE: NVST) ("Envista") will report financial results for the third quarter 2019 on Thursday October 24, 2019,...

Envista Holdings Corporation, a subsidiary of Danaher Corporation (NYSE: DHR), today announced the closing of its previously announced initial public offering (IPO) of 26,768,000 shares of its...

Envista Holdings Corporation, a subsidiary of Danaher Corporation (NYSE: DHR), announced today the pricing of its initial public offering (IPO) of 26,768,000 shares of its common stock at a price...

Envista Holdings Corporation, a subsidiary of Danaher Corporation (NYSE: DHR), today announced it has launched a roadshow for the initial public offering (IPO) of its common stock. Envista is...